Navigation Links
Neuro Kinetics Presenting New Balance & Dizziness Research at American Balance Society Conference
Date:3/3/2011

The paper was co-authored by Dr. Kiderman; along with Dr. Howard Mango and Dr. Cara Makuta, both of the Newport Mesa Audiology Balance & Ear Institute in Newport, California, where the research was conducted.

(Read abstract here.) - link to http://www.neuro-kinetics.com/news_2011abs2.aspx

"We're delighted to be able to offer important new research to the community of balance specialists from around the world," said J. Howison Schroeder, NKI president and CEO. "Great strides are being made in the understanding of balance and equilibrium disorders and we're proud to be a leader in expanding the knowledge base."

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (NKI) is the world leader in eye-tracking technology and non-invasive neuro-otologic diagnostic testing.Central to its product mix and technological advances is the premise that the eye is the portal to the brain.  Research has shown the detection of abnormal eye reflexes can indicate the presence of more than 200 diseases and medical conditions. 

For more than 25 years, NKI has supplied comprehensive neuro-otologic diagnostic tools to audiologists, ENT's, neuro-otologists, neuro-ophthalmologists and neurologists around the globe. The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services. MEDIA CONTACTJohn BuckmanBuckman Communications, for Neuro Kinetics, Inc.+ 1 412-381-2900 or jbuckman@buckman.biz
'/>"/>

SOURCE Neuro Kinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
3. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
4. Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer
5. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
6. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
11. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Calif. , July 29, 2015 /PRNewswire/ ... or the "Company"), the leading provider of ... sciences industry, serving markets including immunotherapies, stem ... manufacturers, animal health, and reproductive medicine, announced ... sale of common stock and warrants (the "Units") under ...
(Date:7/29/2015)... , July 29, 2015   KaloBios Pharmaceuticals, ... company focused on developing innovative therapies to benefit patients ... on oncology, announced today that the U.S. Food and ... drug (IND) application for KB003, an anti-GM-CSF monoclonal antibody ... that the IND is now active. The ...
(Date:7/29/2015)... RARITAN, N.J. , July 29, 2015  Ortho-Clinical ... for five assays under development. The assays address a ... acute kidney injury and cardiac troponin I. The scientific ... for Clinical Chemistry Annual Meeting to be held July ... .   "Ortho Clinical Diagnostics is emerging ...
Breaking Medicine Technology:Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3
... - Life Sciences Seasonal Appeal to Raise ... is changing the face of life science consulting, is delighted ... the unique opportunity for individuals from the life sciences industry ... from the pharmaceutical and venture capital industries. The ...
... Swick & Foti, LLC announces that the United ... Division approved the following announcement of a proposed ... publicly-traded securities of Acura Pharmaceuticals, Inc. (NASDAQ: ACUR): ... WHO PURCHASED OR OTHERWISE ACQUIRED THE PUBLICLY-TRADED SECURITIES ...
Cached Medicine Technology:Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries 2Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries 3Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries 4Kahn Swick & Foti, LLC Announces Class Action Settlement on Behalf of Purchasers of Publicly-Traded Securities of Acura Pharmaceuticals, Inc. -- ACUR 2Kahn Swick & Foti, LLC Announces Class Action Settlement on Behalf of Purchasers of Publicly-Traded Securities of Acura Pharmaceuticals, Inc. -- ACUR 3
(Date:7/30/2015)... ... July 30, 2015 , ... The renowned Brain ... its history of funding brain aneurysm research. , Each year, the Brain ... toward scientific research directed at early detection, improved treatment modalities, and technological advances ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... manufacturing and packaging services for consumer brands, recently completed a consolidation of all ... MD. Previously, the company operated out of two separate locations situated 11 miles ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... to highlight the right and necessity for women to ensure their children have ... healthy development of children from pre-birth by offering discount cards for many prescription ...
(Date:7/29/2015)... California (PRWEB) , ... July 30, 2015 , ... Avid ... Hendrix Dorton Arena Raleigh North Carolina concert posters. The same poster art was used ... printed by Globe Poster based in Baltimore and are classic boxing style concert posters. ...
(Date:7/29/2015)... ... July 30, 2015 , ... ... M.S., MSTi, as a 2015-2016 inductee into the NAPW VIP Woman of the ... mental health counseling. With more than 700,000 members and over 200 Local Chapters, ...
Breaking Medicine News(10 mins):Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 4Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:NAPW Inducts Laura Ballard, Lead Clinician / Founder, Abundant Transformation / Evergreen Professional Counseling, Into its VIP Woman of the Year Circle 2
... BRONX, N.Y., Aug. 3 Seven out of ten U.S. children ... heart disease, according to a study by researchers at Albert Einstein College ... deficiency could place millions of children at risk for high blood pressure ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090803/DC55348 ) , , ...
... suggests the virus continues to change , SUNDAY, Aug. 2 ... evidence that the AIDS virus traveled from gorilla to human, ... scientists race to vanquish it. , French scientists reported Sunday ... carried a strain of the AIDS virus that is closely ...
... , , MANCHESTER, ... the world are turning to cosmetic surgery in increasing numbers, driven ... ("man boobs".) , , Male cosmetic surgery rates ... where the stigma attached to male cosmetic surgery has all but ...
... FRANCISCO (August 1, 2009)Non-small cell lung cancer patients who ... erlotinib, Fox Chase Cancer Center researchers reported today at ... Study of Lung Cancer. Both cetuximab (Erbitux) and ... and the assumption has been that once a patient ...
... NASHVILLE, Tenn., Aug. 1 HCA Healthcare announces the following Webcast: , , ... Webcast , , When: August 6, ... http://www.videonewswire.com/event.asp?id=60459 , , How: ... web at the address above. , , Contact: ...
... ... shifting benefits programs. , ... Indianapolis, IN (PRWEB) August 1, 2009 -- Member Firms of United Benefit ... announced that registration for the August webinar titled "Electronic Distribution of SPDs and other ...
Cached Medicine News:Health News:Millions Of U.S. Children Low In Vitamin D 2Health News:Scientists ID First Human With Gorilla Strain of HIV 2Health News:Men Around the World Seek Cosmetic Surgery 2Health News:Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy 2Health News:Webinar Offers Tips for Meeting Compliance Communications and Provides HRCI Credit for Human Resource Professionals 2Health News:Webinar Offers Tips for Meeting Compliance Communications and Provides HRCI Credit for Human Resource Professionals 3
... Oxinium (oxidized zirconium) isn't a new implant. ... Smith & Nephew. Wear debris can be ... almost nil, addressing the needs of the ... are all improved. Initially, Oxinium is available ...
... anatomic knee system was ... minimize polyethylene wear between ... minimize contact stress associated ... achieve a well balanced ...
Simplified Design-Based on 15 Years of Experience...
... than a decade of in-vivo research, the ... study of knee kinematics through fluoroscopic review, ... analysis.,As a result of this exhaustive analysis ... in total knees, the 3DKnee implant provides ...
Medicine Products: